2020
DOI: 10.1186/s12978-020-01009-3
|View full text |Cite
|
Sign up to set email alerts
|

Looking beyond the numbers: quality assurance procedures in the Global Network for Women’s and Children’s Health Research Maternal Newborn Health Registry

Abstract: Background Quality assurance (QA) is a process that should be an integral part of research to protect the rights and safety of study participants and to reduce the likelihood that the results are affected by bias in data collection. Most QA plans include processes related to study preparation and regulatory compliance, data collection, data analysis and publication of study results. However, little detailed information is available on the specific procedures associated with QA processes to ensure high-quality … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
6
1

Relationship

5
2

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…11 Indiana School of Medicine, University of Indiana, Indianapolis, IN, USA. 12 University of Colorado School of Medicine, Denver, CO, USA. 13 Thomas Jefferson University, Philadelphia, PA, USA.…”
Section: Availability Of Data and Materialsmentioning
confidence: 99%
See 1 more Smart Citation
“…11 Indiana School of Medicine, University of Indiana, Indianapolis, IN, USA. 12 University of Colorado School of Medicine, Denver, CO, USA. 13 Thomas Jefferson University, Philadelphia, PA, USA.…”
Section: Availability Of Data and Materialsmentioning
confidence: 99%
“…Interval maternal and newborn health and vital status are assessed at a third visit on day 42 after birth. The same study protocol and similar operational mechanisms are utilized at all the sites across the GN [12].…”
Section: Introductionmentioning
confidence: 99%
“…A major strength of our cohort is the data originated from a prospectively designed study. Subjects were enrolled early in pregnancy as part of the ASPIRIN trial, and tracked prospectively through delivery to 42 days postpartum, as part of our established, population-based maternal newborn health registry, which employs rigorous quality assurance procedures [42]. This design ensured that, as much as possible, all pregnancies were tracked, not just those enrolling late in gestation or even after delivery.…”
Section: Discussionmentioning
confidence: 99%
“…To provide an overall picture of pregnancy and its outcomes and trends over time in LMIC, the Global Network developed this collection of papers. This supplement features 19 publications describing the Global Network and the Registry data from 2010 to 2018 [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. This supplement covers a wide variety of topics related to pregnancy outcome and neonatal health, focusing on ways to improve outcomes for the pregnant women and their fetuses and newborns.…”
Section: Introductionmentioning
confidence: 99%
“…Finally, the Global Network has put a great deal of effort into improving not only the quality of care for its subjects, but also into improving the quality of the data being collected. While metrics to assess quality have been a cornerstone of the Registry since its beginning, over time, improvements in data quality have occurred as reported by Garces et al [ 17 ]. Patel et al evaluated the quality of care around delivery related to early neonatal mortality [ 18 ].…”
mentioning
confidence: 99%